Treatment of Discoid Lupus Erythematosus with Localized Skin Lesions
This protocol covers the management of discoid lupus erythematosus (DLE) presenting as localized skin lesions in patients without severe or widespread involvement, without risk of scarring or progression to systemic disease, and who are not pregnant or breastfeeding.
Clinical Scenario
- Localized skin lesions of discoid lupus erythematosus
- No severe or widespread skin involvement
- No risk of scarring or development of systemic disease
- Not pregnant; not breastfeeding
Treatment Approach
First-line management for localized DLE lesions is topical. The structured protocol specifies which topical agents to use — with tailored options for active lesions, especially on the face — along with guidance on appropriate duration and sequencing.
Full agent selection, sequencing, and duration criteria are in the structured protocol below.
References
- Topical corticosteroids are the mainstay in the treatment of localized CLE being effective in all subtypes.
- We recommend topical corticosteroids as first-line treatment for a time limited up to some weeks in all CLE lesions.
- In active, oedematous CLE lesions, particularly on the face, we recommend calcineurin inhibitors (0.1% tacrolimus ointment) as an alternative first-line or as a second-line topical treatment option.
View source ↗